HER2 Support Group Forums - View Single Post - Novartis Inks Agreement For Immunogen's "TAP" ADC Technology

'lizbeth · 10-11-2013, 08:58 AM

Excellent news, especially since Novartis has so many breast cancer therapies in the pipeline. Hopefully this will lead to more ADC treatments. Perhaps this time, they can link a less toxic chemo with a MAB and increase both quantity and Quality of life.

10-11-2013, 08:58 AM	#2
'lizbeth Senior Member Join Date: Apr 2008 Location: Sunny San Diego Posts: 2,214	Re: Novartis Inks Agreement For Immunogen's "TAP" ADC Technology Excellent news, especially since Novartis has so many breast cancer therapies in the pipeline. Hopefully this will lead to more ADC treatments. Perhaps this time, they can link a less toxic chemo with a MAB and increase both quantity and Quality of life.